Budesonide: all 303 studies that test it
Page 3 of 4. Open to participants first (25), then studies with results posted, then the rest; newest registration first within each.
- Inhaled Budesonide for Non-ventilated Infants at High Risk of Bronchopulmonary Dysplasia: the i-BUD Pilot StudyWithdrawnNCT01895075Phase 2
- Two Different Dosages of Nebulized Steroid Versus Parenteral Steroid in the Management of COPD ExacerbationsCompletedNCT01865500Phase 4
- Effect of Nasal Steroids in Snoring IntensityCompletedNCT01849406Phase 1
- Dietetic Versus Topical Steroids for Pediatric Eosinophilic EsophagitisCompletedNCT01846962Phase 4
- Trial of Directed High-dose Nasal Steroids on Residual Smell Loss in Sinus Patients After Sinus SurgeryWithdrawnNCT01814618Phase 2
- Effect of Nebulized Budesonide on Preventing Postextubation Complications in Critically PatientsStatus unknownNCT01786070Not applicable
- The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal DiseaseCompletedNCT01738035Phase 2
- Effect of Symbicort on Sleep Quality in Patients With EmphysemaStatus unknownNCT01602523Phase 3
- Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans Following Stem Cell TransplantationCompletedNCT01560689Phase 2
- Pathogenetic Mechanisms of Chronic Obstructive Pulmonary DiseasesCompletedNCT01378039Not applicable
- Improvement of FeNO and FEF25-75 After Inhaled Corticosteroid Treatment of AsthmaCompletedNCT01340118Phase 4
- SOIBD Collagenous Colitis Maintenance StudyCompletedNCT01278082Phase 3
- Pilot Study of Topical Steroid for Prevention of Chronic Lung Disease in Extremely Premature Infants.Status unknownNCT01268215Phase 2
- Evaluation of an Oxygen Enhanced Magnetic Resonance Imaging Method on Patients With Chronic Obstructive Pulmonary Disease During 8 Weeks Treatment With Either Symbicort Turbuhaler or Oxis TurbuhalerCompletedNCT01257048Early Phase 1
- Symbicort in Airway Predominant Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01253473Phase 4
- The Use of Fractional Exhaled Nitric Oxide in the Identification of Non-adherence in Difficult AsthmaCompletedNCT01219036Not applicable
- Budesonide Versus Mesalazine Versus Placebo in Lymphocytic ColitisCompletedNCT01209208Phase 3
- AKITA Inhaled Steroid Suspension for Inhalation (AICS) in Subjects With AsthmaCompletedNCT01200108Phase 2
- Effect on Adrenal Function of Budesonide Versus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01186653Phase 4
- 9 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's DiseaseCompletedNCT01086553Phase 3
- Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary DysplasiaCompletedNCT01035190Phase 3
- A Comparative Study Between Foraseq and Formoterol/Budesonide Inhalation Capsules in Patients with AsthmaCompletedNCT01001364Phase 3
- Differential Trough Effects of 'Triple Therapy' on Pulmonary Function in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00996697Phase 4
- Compare Captisol-Enabled (CE) Budesonide + Azelastine Nasal Solution and Rhinocort Aqua + Astelin in an Environmental Exposure Chamber (EEC) Study of Allergic RhinitisCompletedNCT00940953Phase 2
- Compare CE-Budesonide Nasal Solution & Rhinocort Aqua in an EEC Study of ARCompletedNCT00938613Phase 2
- Efficacy of Oral Leukotriene in Long Term Therapy of Mild and Moderate Obstructive Sleep Apnea Syndrome in ChildrenCompletedNCT00912171Phase 4
- Efficacy and Safety Study of Budesonide to Treat Oral Chronic Graft vs Host Disease (cGvHD)CompletedNCT00887263Phase 3
- Prevention of Chronic Lung Disease (CLD) in Preterm InfantsStatus unknownNCT00883532Phase 4
- Saline Challenge in Monitoring Asthma ControlCompletedNCT00859274Not applicable
- Budesonide 3x3mg/d Versus Prednisone in Active Autoimmune HepatitisCompletedNCT00838214Phase 2/3
- Budesonide Foam Versus Placebo for Prevention of Acute Radiation ProctitisTerminatedNCT00828230Phase 2
- Innate Immune Responses in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00826163Phase 3
- Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative StudyCompletedNCT00767221Phase 2
- Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC)CompletedNCT00747110Phase 3
- Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC)TerminatedNCT00746486Phase 3
- Nebulized Budesonide for Children Who Are Hospitalized for Acute WheezingCompletedNCT00733473Phase 4
- Budesonide for Emergency Treatment of Acute Wheezing in ChildrenCompletedNCT00733317Phase 4
- Effects of Budesonide & Budesonide/Formoterol on Smoking Asthmatic SubjectsCompletedNCT00691951Phase 3
- Inhaled Corticosteroids on Airway Smooth Muscle in AsthmaWithdrawnNCT00661973Phase 4
- Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort Pressurized Metered-dose Inhaler (pMDI) or Oxis TurbuhalerCompletedNCT00658255Phase 2
- Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEMCompletedNCT00652392Phase 3
- Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 160/4.5CompletedNCT00652002Phase 3
- Titratable Dosing in Moderate to Severe AsthmaticsCompletedNCT00651768Phase 3
- Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 80/4.5CompletedNCT00651651Phase 3
- Symbicort in Asthmatic Children - SEEDLINGCompletedNCT00651547Phase 3
- Symbicort Onset of Action 2CompletedNCT00646009Phase 3
- New Version Pulmicort Turbuhaler USA AdultsCompletedNCT00642187Phase 3
- New Version Pulmicort Turbuhaler USA ChildrenCompletedNCT00642161Phase 3
- Adults With Moderate to Severe AsthmaCompletedNCT00642122Phase 3
- New Nasal Applicator / New Formulation - User StudyCompletedNCT00641979Phase 2
- Inhaled Steroid Treatment as Regular Therapy in Early AsthmaCompletedNCT00641914Phase 4
- Assess the Efficacy and Safety of Rhinocort AquaCompletedNCT00641693Phase 2
- Rhinocort Aqua Versus Placebo and Fluticasone PropionateCompletedNCT00641680Phase 3
- Pulmicort Respules(Budesonide Inhalation Suspension) vs Singulair, ChildrenCompletedNCT00641472Phase 4
- Varicella Vaccination With PulmicortCompletedNCT00641446Phase 4
- Children, Perennial Allergic Rhinitis (PAR), l-t GrowthCompletedNCT00641212Phase 4
- Prospective Evaluation of the Efficacy of Budesonide/Formoterol in Bronchiolitis Obliterans in AHSCTCompletedNCT00624754Phase 2
- A Pilot Study Involving an Asthma Management Program for Inner-city Early Head Start ChildrenStatus unknownNCT00624429Phase 4
- Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune HepatitisWithdrawnNCT00587119Not applicable
- Pulmicort Respules on Relapse Rates After Treatment in the EDWithdrawnNCT00584636Phase 4
- Nasal Budesonide in Children With Rhinitis and/or Mild Obstructive Sleep Apnea SyndromeCompletedNCT00560586Phase 4
- Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic ChildrenCompletedNCT00522782Phase 4
- Open-label, Safety and Efficacy Study of Pulmicort® Turbuhaler® in Japanese Children With Bronchial AsthmaCompletedNCT00504062Phase 3
- Effect of Different Doses of Budesonide on Markers of Bone Metabolism in Children With AsthmaCompletedNCT00487773Phase 4
- Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPDCompletedNCT00476099Phase 3
- Childhood Asthma Research and Education (CARE) Network Trial - Montelukast or Azithromycin for Reduction of Inhaled Corticosteroids in Childhood Asthma (MARS)TerminatedNCT00471809Phase 4
- Comparison of Combination Therapy: Montelukast and Inhaled Steroid on Exercise Induced BronchoconstrictionCompletedNCT00462592Phase 3
- Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous ColitisCompletedNCT00450086Phase 3
- Efficacy and Safety Study of Symbicort Turbuhaler in Chinese Patients With COPDCompletedNCT00421122Phase 3
- Initiation of Chronic Asthma Care Regimens in the Pediatric Emergency DepartmentWithdrawnNCT00388739Not applicable
- Short- and Long Term Growth in Children With AsthmaCompletedNCT00380484Phase 4
- Prevention of Asthma Relapse After Discharge From EmergencyCompletedNCT00326053Phase 3
- Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)CompletedNCT00319488Not applicable
- Real Life Effectiveness in Asthma of Symbicort Single Inhaler TherapyCompletedNCT00319306Phase 3
- Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD)CompletedNCT00300118Phase 3
- SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent AsthmaCompletedNCT00290264Phase 3
- SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild AsthmaCompletedNCT00288379Phase 3
- Effect of Budesonide / Formoterol Combination in Repeated AMP ProvocationsCompletedNCT00272753Phase 4
- Budesonide for Eosinophilic EsophagitisCompletedNCT00271349Phase 2
- SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and AdultsCompletedNCT00259792Phase 3
- Comparison Between Symbicort® and Prednisolone in COPDCompletedNCT00259779Phase 3
- SHARE - Symbicort and Health Economics in a Real Life EvaluationCompletedNCT00259766Phase 3
- Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With AsthmaCompletedNCT00255255Phase 3
- Efficacy & Safety of Symbicort® TURBUHALER® 160/4.5 µg Twice Daily & Pulmicort® TURBUHALER® 200 µg Twice Daily + Theolong® Tablet 200 mg Twice Daily in Japanese Asthmatic PatientsCompletedNCT00252785Phase 3
- A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler®CompletedNCT00244608Phase 3
- Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mgCompletedNCT00242775Phase 3
- SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & AdultsCompletedNCT00238784Phase 3
- Symbicort Single Inhaler Therapy for Asthma in a General Practice SettingCompletedNCT00235911Phase 3
- PreAsthmaControl (PAC)CompletedNCT00234390Phase 4
- Efficacy Study of the Effect of Budesonide on EmphysemaCompletedNCT00232674Phase 4
- Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial AsthmaCompletedNCT00232648Phase 3
- A Study to Assess the Concentration of Budesonide in Breast Milk From Asthmatic WomenCompletedNCT00228475Phase 4
- Effects of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00202189Phase 4
- Treatment of Microscopic ColitisTerminatedNCT00184171Not applicable
- Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell TransplantationCompletedNCT00180089Phase 3
- Budesonide for Maintenance Treatment of Collagenous ColitisCompletedNCT00180076Phase 3
- Budesonide Treatment for Lymphocytic ColitisCompletedNCT00180050Phase 3
- A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide)CompletedNCT00175747Phase 2/3
- Long-Term Treatment of Collagenous Colitis With BudesonideStatus unknownNCT00139165Phase 3
- A Study of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral BudesonideCompletedNCT00135408Phase 2